Trials / Completed
CompletedNCT02303522
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)
A Retrospective Pooled Analysis of Complete Remission Among Pediatric Patients With Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 207 (estimated)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Not accepted
Summary
An historical data comparator study for children with relapsed/refactory acute lymphoblastic leukemia (ALL).
Detailed description
A retrospective observational study reviewing historical complete remission for pediatric patients who had either relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Other: not applicable - observational study | No intervention exists as this is a retrospective observational study |
Timeline
- Start date
- 2014-12-09
- Primary completion
- 2015-01-22
- Completion
- 2015-01-22
- First posted
- 2014-12-01
- Last updated
- 2020-05-06
Locations
3 sites across 3 countries: Austria, Germany, Italy
Source: ClinicalTrials.gov record NCT02303522. Inclusion in this directory is not an endorsement.